GLOBUS MEDICAL INC (GMED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q3 '16: 135.7M Q4 '16: 151.6M Q1 '17: 155.8M Q2 '17: 152.4M Q3 '17: 151.7M Q4 '17: 176M Q1 '18: 174.4M Q2 '18: 173.4M Q3 '18: 169.2M Q4 '18: 195.9M Q1 '19: 182.9M Q2 '19: 194.5M Q3 '19: 196.2M Q4 '19: 211.7M Q1 '20: 190.6M Q2 '20: 148.9M Q3 '20: 216.1M Q4 '20: 233.4M Q1 '21: 227.3M Q2 '21: 251M Q3 '21: 229.7M Q4 '21: 250M Q1 '22: 230.5M Q2 '22: 263.6M Q3 '22: 254.1M Q4 '22: 274.5M Q1 '23: 276.7M Q2 '23: 291.6M Q3 '23: 383.6M Q4 '23: 616.5M Q1 '24: 606.7M Q2 '24: 629.7M Q3 '24: 625.7M Q4 '24: 657.3M Q1 '25: 598.1M Q2 '25: 745.3M Q3 '25: 769M Q4 '25: 826.4M Q1 '26: 759.9M Q2 '26: 789.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 150M 300M 450M Q3 '14: 90.1M Q4 '14: 97.5M Q1 '15: 99.5M Q2 '15: 101M Q3 '15: 104.1M Q4 '15: 107.6M Q1 '16: 107.7M Q2 '16: 104.8M Q3 '16: 104.2M Q4 '16: 112.6M Q1 '17: 120.2M Q2 '17: 115.2M Q3 '17: 114.9M Q4 '17: 135.2M Q1 '18: 136.4M Q2 '18: 135.7M Q3 '18: 131.4M Q4 '18: 150M Q1 '19: 141.1M Q2 '19: 150.5M Q3 '19: 150.8M Q4 '19: 162.9M Q1 '20: 141.7M Q2 '20: 98.3M Q3 '20: 159M Q4 '20: 172.6M Q1 '21: 172.3M Q2 '21: 187.2M Q3 '21: 171.2M Q4 '21: 188.2M Q1 '22: 171.4M Q2 '22: 195.2M Q3 '22: 188.7M Q4 '22: 203.9M Q1 '23: 205.9M Q2 '23: 215.1M Q3 '23: 248.2M Q4 '23: 351M Q1 '24: 365.2M Q2 '24: 369.7M Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24

Operating Income Quarterly

-70M 0 70M 140M 210M Q3 '16: 37.6M Q4 '16: 35.7M Q1 '17: 40.3M Q2 '17: 37.4M Q3 '17: 35.8M Q4 '17: 48.4M Q1 '18: 45.6M Q2 '18: 42.1M Q3 '18: 38.3M Q4 '18: 0 Q1 '19: 37.1M Q2 '19: 42.9M Q3 '19: 42.1M Q4 '19: 50M Q1 '20: 28.4M Q2 '20: -25.6M Q3 '20: 50M Q4 '20: 58.5M Q1 '21: 54.5M Q2 '21: 45.9M Q3 '21: 53.3M Q4 '21: 18.2M Q1 '22: 46.4M Q2 '22: 67.8M Q3 '22: 59.7M Q4 '22: 54M Q1 '23: 56.4M Q2 '23: 66.2M Q3 '23: 404K Q4 '23: 10.1M Q1 '24: 8M Q2 '24: 49.6M Q3 '24: 48.1M Q4 '24: 60.3M Q1 '25: 97M Q2 '25: 76.1M Q3 '25: 137.4M Q4 '25: 169.3M Q1 '26: 150.4M Q2 '26: 182.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-70M 0 70M 140M 210M Q3 '16: 26.2M Q4 '16: 24.3M Q1 '17: 28.7M Q2 '17: 28.7M Q3 '17: 25.6M Q4 '17: 24.4M Q1 '18: 39.5M Q2 '18: 45M Q3 '18: 35.2M Q4 '18: 36.8M Q1 '19: 33.2M Q2 '19: 38.2M Q3 '19: 38.3M Q4 '19: 45.5M Q1 '20: 25.9M Q2 '20: -20.8M Q3 '20: 44.2M Q4 '20: 53M Q1 '21: 45.3M Q2 '21: 41.5M Q3 '21: 47.2M Q4 '21: 15.1M Q1 '22: 38.1M Q2 '22: 54.6M Q3 '22: 47.4M Q4 '22: 50.1M Q1 '23: 49.1M Q2 '23: 57.7M Q3 '23: 998K Q4 '23: 15M Q1 '24: -7.1M Q2 '24: 31.8M Q3 '24: 51.8M Q4 '24: 26.5M Q1 '25: 75.5M Q2 '25: 202.8M Q3 '25: 119M Q4 '25: 140.6M Q1 '26: 124.3M Q2 '26: 151.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 100M 200M 300M Q1 '17: 35.6M Q2 '17: 37.2M Q3 '17: 36.8M Q4 '17: 40.9M Q1 '18: 38M Q2 '18: 37.6M Q3 '18: 37.8M Q4 '18: 0 Q1 '19: 41.8M Q2 '19: 44M Q3 '19: 45.4M Q4 '19: 48.8M Q1 '20: 48.9M Q2 '20: 50.6M Q3 '20: 57.1M Q4 '20: 60.9M Q1 '21: 55M Q2 '21: 63.8M Q3 '21: 58.6M Q4 '21: 61.8M Q1 '22: 59.2M Q2 '22: 68.5M Q3 '22: 65.5M Q4 '22: 70.6M Q1 '23: 70.8M Q2 '23: 76.5M Q3 '23: 135.4M Q4 '23: 265.5M Q1 '24: 241.5M Q2 '24: 260M Q3 '24: 270.5M Q4 '24: 263.4M Q1 '25: 195.4M Q2 '25: 248.8M Q3 '25: 252.5M Q4 '25: 261.1M Q1 '26: 234.1M Q2 '26: 241.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

0 90M 180M 270M Q3 '16: 42.7M Q4 '16: 26.3M Q1 '17: 53.4M Q2 '17: 26M Q3 '17: 34.8M Q4 '17: 44.8M Q1 '18: 52.3M Q2 '18: 33.3M Q3 '18: 96.1M Q4 '18: 0 Q1 '19: 39.2M Q2 '19: 22.6M Q3 '19: 55.9M Q4 '19: 54.3M Q1 '20: 42.3M Q2 '20: 23.1M Q3 '20: 53.2M Q4 '20: 80.2M Q1 '21: 63.6M Q2 '21: 59.2M Q3 '21: 77.3M Q4 '21: 76.3M Q1 '22: 44.7M Q2 '22: 36.9M Q3 '22: 32.9M Q4 '22: 64M Q1 '23: 53.3M Q2 '23: 35M Q3 '23: 50.5M Q4 '23: 104.7M Q1 '24: 52.4M Q2 '24: 54.3M Q3 '24: 203.7M Q4 '24: 210.3M Q1 '25: 177.3M Q2 '25: 77.9M Q3 '25: 249.7M Q4 '25: 248.6M Q1 '26: 202.4M Q2 '26: 209.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

0 80M 160M 240M Q3 '16: 36.1M Q4 '16: 12.1M Q1 '17: 41.9M Q2 '17: 12.4M Q3 '17: 22M Q4 '17: 31.4M Q1 '18: 39.9M Q2 '18: 18.5M Q3 '18: 63.5M Q4 '18: 0 Q1 '19: 11M Q2 '19: 7.9M Q3 '19: 43.8M Q4 '19: 38.5M Q1 '20: 20M Q2 '20: 13.1M Q3 '20: 35.9M Q4 '20: 66.1M Q1 '21: 49.9M Q2 '21: 50.8M Q3 '21: 59.5M Q4 '21: 59.2M Q1 '22: 24.7M Q2 '22: 13.1M Q3 '22: 20.9M Q4 '22: 45.6M Q1 '23: 37.3M Q2 '23: 17.2M Q3 '23: 28.9M Q4 '23: 81.8M Q1 '24: 23.8M Q2 '24: 26.5M Q3 '24: 161.7M Q4 '24: 193.2M Q1 '25: 141.2M Q2 '25: 31.3M Q3 '25: 213.9M Q4 '25: 202.4M Q1 '26: 162.7M Q2 '26: 176.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '13: 94M Q3 '13: 94.4M Q1 '14: 95.2M Q2 '14: 95.5M Q3 '14: 95.5M Q1 '15: 95.9M Q2 '15: 96M Q3 '15: 96.1M Q1 '16: 96.3M Q2 '16: 96.4M Q3 '16: 96.5M Q1 '17: 97.1M Q2 '17: 97.8M Q3 '17: 97.8M Q1 '18: 100.5M Q2 '18: 101.5M Q3 '18: 101.8M Q1 '19: 101.4M Q2 '19: 101.6M Q3 '19: 102.1M Q1 '20: 102.1M Q2 '20: 97.5M Q3 '20: 100.5M Q1 '21: 102.4M Q2 '21: 103.5M Q3 '21: 104.4M Q1 '22: 104.1M Q2 '22: 102.9M Q3 '22: 101.4M Q1 '23: 102.2M Q2 '23: 101.8M Q3 '23: 115.2M Q1 '24: 135.4M Q2 '24: 137M Q3 '24: 138.1M Q1 '25: 139.8M Q2 '25: 136.5M Q3 '25: 135.4M Q1 '26: 138.2M Q2 '26: 137.4M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q3 '16: 1.22 Q4 '16: 1.08 Q1 '17: 1.09 Q2 '17: 1.11 Q3 '17: 1.10 Q4 '17: 1.10 Q1 '18: 1.19 Q2 '18: 1.34 Q3 '18: 1.43 Q4 '18: 1.54 Q1 '19: 1.48 Q2 '19: 1.42 Q3 '19: 1.45 Q4 '19: 1.53 Q1 '20: 1.45 Q2 '20: 0.86 Q3 '20: 0.92 Q4 '20: 1.00 Q1 '21: 1.19 Q2 '21: 1.80 Q3 '21: 1.81 Q4 '21: 1.43 Q1 '22: 1.36 Q2 '22: 1.49 Q3 '22: 1.51 Q4 '22: 1.86 Q1 '23: 1.97 Q2 '23: 2.01 Q3 '23: 1.55 Q4 '23: 1.15 Q1 '24: 0.62 Q2 '24: 0.28 Q3 '24: 0.65 Q4 '24: 0.75 Q1 '25: 1.34 Q2 '25: 2.60 Q3 '25: 3.10 Q4 '25: 3.93 Q1 '26: 4.29 Q2 '26: 3.90 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.